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Abstract: Classical methods of wastewater treatment are often not suitable for 
the treatment of pharmaceutical waste. The previous studies have shown that 
the use of the advanced oxidation procedures (AOP) can lead to a more effi-
cient degradation of various biologically active compounds, which are active 
pharmaceutical ingredients of applied drugs. The aim of this paper is the appli-
cation of the plasma technology on the degradation of a two active pharma-
ceutical ingredients (APIs, diazepam and alprazolam) and the finished products 
(Bensedin® and Ksalol®) using the dielectric barrier discharge (DBD) reactor 
for AOP. We studied the degradation rate of these pharmaceuticals, depending 
on the number of passes through the reactor. This degradation method was 
efficient 61 % for diazepam and 95 % alprazolam. We also examined the inf-
luence of the pH adjustment between the passes of APIs through the DBD reac-
tor. The degradation rate of APIs and the finished products was monitored by 
the high performance liquid chromatography (HPLC) technique, using a photo-
diode array detector. The concentration of the dissolved ozone was determined 
using the iodometric procedure. 
Keywords: alprazolam; diazepam; oxidation; pollutants. 
INTRODUCTION 
Modern society faces the increasing use of pharmaceutical products and, 
consequently, the increasing amounts of these products end up in the natural 
environment.1–10 What is difficult to control is the generation of pharmaceutical 
waste made by the users of pharmaceutical products.  
Unlike other pollutants whose amounts in the environment have been 
reduced by the introducing of stricter laws, it is very difficult to apply equivalent 
standards when medicinal products are considered, taking into account all the 
benefits they brought to human and animal populations. In the light of the facts 
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above, the amounts of pharmaceutical waste may also be expected to increase in 
the future.  
Pharmaceutical waste is generated either during the process of an active 
pharmaceutical ingredient (API)/finished product manufacturing, or from the 
APIs/finished products that are past their expiry dates. 
The finished products containing diazepam and alprazolam or any other ben-
zodiazepine as their active ingredients, belong to a group of the most commonly 
used pharmaceutical products. In nearly all developing countries these are among 
the top twenty most commonly used pharmaceutical products.11 
By their nature, the pharmaceutical products are the biologically active com-
pounds. The parameters used to monitor the effect of the biologically active 
compounds on the living organisms are biodegradation and bioaccumulation. 
Pharmaceutical waste belongs to the group of primary pollutants, being toxic for 
both humans and animals; it is poorly degradable12 and is not readily removed. A 
number of investigations shown the standard wastewater treatment methods as 
unreliable in the treatment of the pharmaceutical waste. Such methods are gen-
erally non-destructive to diazepam and to the structurally similar substances.8,13–15 
The application of advanced oxidation processes (AOP) may result in a more 
effective degradation of such substances.16,17 These processes involve the creat-
ion of radicals (e.g., hydroxyl radicals) and their reaction with the sample. 
One of the most recent AOP technologies is the plasma-based technology, 
which finds the increasing application in the water treatment for the purpose of 
removing a variety of different pollutants.18–23 
One of the methods to generate plasma is the dielectric barrier discharge 
(DBD). DBD reactor, as a system for ozone generating, was recently developed 
and described.24 This reactor has been proved to be applicable and very effective 
in a variety of fields, such as the removal of phenol and chlorophenols from 
water,25 the degradation of phenol solutions,26 decolorization of reactive textile 
dyes,27 simultaneous removal of NOx and SO2 from flue gas in a coal-combustion 
power plant,28 degradation of herbicides,29,30 removal of ibuprofen from aqueous 
solutions,31 degradation of textile azo dye,32 as well as the degradation of anionic 
surfactants. 33 
Herein, we report for the first time, the degradation of diazepam and alpra-
zolam, as well as of their respective finished products Bensedin® and Ksalol®, 
depending on the number of passes through the DBD reactor. 
EXPERIMENTAL 
For the purpose of this paper, the APIs (diazepam and alprazolam) and the finished pro-
ducts (Bensedin® and Ksalol®) of Galenika a.d., Belgrade, Serbia, were used. All solutions 
were prepared immediately before their use. 
(CC) 2017 SCS. All rights reserved.
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Diazepam solution 
A solution of 50 mg L-1 concentration was prepared by dissolving 100 mg of diazepam in 
2 L of water (double-distilled), and adding 0.5 mL of concentrated hydrochloric acid (Merck 
p.a.), due to its poor solubility. 
Bensedin® solution 
Bensedin® product containing 5 mg of diazepam, as active ingredient, was used. Twenty 
tablets were dissolved in 2 L of water, adding 0.5 mL of concentrated hydrochloric acid in 
order to obtain the same concentration of diazepam (50 mg L-1).  
Alprazolam solution 
A solution of 50 mg L-1 was prepared by dissolving 100 mg of alprazolam in 2 L of 
water, and adding 1.7 mL of concentrated hydrochloric acid due to its poor solubility. 
Ksalol® solution 
Ksalol® product containing 1 mg of alprazolam, as active ingredient, was used. One 
hundred tablets were dissolved in 2 L of water, adding 1.7 mL of concentrated hydrochloric 
acid, in order to obtain the same concentration of alprazolam (50 mg L-1). 
The reagents used for high performance liquid chromatography (HPLC) analysis were: 
acetonitrile (J. T. Baker, HPLC grade), methanol (J. T. Baker, HPLC grade), potassium dihyd-
rogen phosphate (Merck), sodium hydroxide (Fluka), ammonium acetate (Fluka) and glacial 
acetic acid (Merck). 
Iodometric procedure 
Prior to the experiment, the concentration of dissolved ozone was determined using the 
standard iodometric procedure. The concentration of dissolved ozone was measured by samp-
ling from the upper reservoir and calculated for one pass through the ozone generator.24,25 
In the ozonated water sample 5 mL of 20 vol. % solution of sulfuric acid (Merck) and 
potassium iodide (Sigma-Aldrich) were added in excess. The sample was left for 10 min in a 
dark place and titrated with 0.1 mol L-1 solution of sodium thiosulfate. The titrant was added 
until the yellow color of liberated iodine faded. After the addition of 4 mL of starch indicator 
solution titration was continued until the blue colour disappeared. 
Degradation procedure 
Degradation of APIs (diazepam and alprazolam) and their respective finished products 
(Bensedin® and Ksalol®) was carried out by means of an AOP, using the non-thermal plasma 
reactor based on coaxial DBD.24,25 
This coaxial DBD reactor is of fairly simple structure. The both coaxial electrodes are 
coated with glass as a dielectric and located at the discharge side. The system comprises off 
three reactors connected in parallel. The length of one DBD reactor, i.e., the length of an elec-
trode is 40 cm and the distance between the electrodes is 3 mm. The electrode diameter is 20 
mm. 
Solutions of APIs and of their respective finished products were pumped to the top of the 
reactor through a hollow central electrode using a peristaltic pump. From the top of the 
reactor, the solutions flowed as a thin film over the glass that was coating the inner electrode. 
The treated solutions were collected in a receptacle at the bottom of the reactor. The total flow 
rate through the system of three parallel DBD reactors was 210 mL min-1.  
One series of passes of diazepam and alprazolam solutions was carried out without the 
pH adjustment (pH 3.00). The treated samples were recirculated 12 times for diazepam and 
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alprazolam, with a 100 mL aliquot withdrawn after each pass of the solution through the DBD 
reactor. 
After a single series of passes of Bensedin® and Ksalol®, where the initial pH was 3.00, 
and was not modified, the treated sample was recirculated 12 times. After each pass of the 
solution through the DBD reactor a 100 mL aliquot was withdrawn. 
For a series of experiments with diazepam and alprazolam with the pH adjustment, one 
series of passes was carried out with an initial pH of 3.00. The treated sample was recirculated 
7 times for diazepam and alprazolam. After each pass of the solution through the DBD reactor 
a 100 mL aliquot was withdrawn, while the pH of the remaining solution was adjusted to 3.00 
(using 0.1 mol L-1 hydrochloric acid), and the solution returned for recirculation. 
Analytical procedure 
The determination of degradation rate was performed by HPLC technique using a photo-
diode array detector (Hewlett Packard 1100, Belgrade, Serbia). 
A Zorbax SB-C8 column (250 mm×4.6 mm, 5μm) was used at 30 °C for chromato-
graphic separation in diazepam and Bensedin®. The mobile phase was obtained by mixing 
acetonitrile, methanol and 0.34 g/L aqueous solution of potassium dihydrogen phosphate (its 
pH being previously adjusted to 5 by the addition of sodium hydroxide solution) at the volume 
ratio of 22:34:44. The flow rate of the column was 1 ml/min in the isocratic mode, the inject-
ion volume being 100 µL. The detection wavelength was set to 254 nm.  
A Zorbax SB-Phenyl (250 mm×4.6 mm, 5μm) column was used at 40 °C for chroma-
tographic separation in alprazolam and Ksalol®. The mobile phase consisted of a buffer sol-
ution (a 0.77 g/L aqueous solution of ammonium acetate in water, its pH being adjusted to 4.2 
using glacial acetic acid) and methanol at the volume ratio of 44:56, as the component A and a 
buffer solution (0.77 g/L aqueous solution of ammonium acetate in water, its pH being 
adjusted to 4.2 using glacial acetic acid) and methanol at the volume ratio of 5:95 as the com-
ponent B. The flow rate of the column was 2 ml min-1 in the gradient mode: 2 % B, 15 min, 
2–99 %, 20 min, 99 % B, 5 min. The injection volume was 100 µL. The detection wavelength 
was set to 254 nm. 
RESULTS AND DISCUSSION 
As the emission of ozone takes place in a closed system there are no losses 
of ozone during the generation and dissolution in water.25 D. Manojlović et al.25 
applied this reactor for the removal of phenol from water samples. Depending on 
the experimental conditions, the concentration of dissolved ozone was about 
7-40 mg L-1. These values were higher than 0.2 mg L–1 obtained by using the 
reactor based on the corona needle-to-plate discharge.25  
In our experiment, after approximately 1 h of work, the determined concen-
tration of dissolved ozone in water was 12.9 mg L–1. 
In the first part of the paper we presented the degradation rate of diazepam 
and alprazolam APIs, as well as of their respective finished products Bensedin® 
and Ksalol®, depending on the number of passes through the DBD reactor. The 
rate of degradation of starting compounds was determined by means of HPLC 
technique, using the standard compendial method.  
The results are presented in Tables I and II. 
(CC) 2017 SCS. All rights reserved.
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TABLE I. Increase of the degradation rate (%) of active ingredient (diazepam and alprazolam) 
by passing through the DBD reactor 
Number of passes Active ingredient Diazepam Alprazolam 
0 0 0 
1 11.00 13.06 
2 21.40 20.95 
3 28.87 32.39 
4 31.18 42.89 
5 38.00 51.21 
6 39.96 64.05 
7 43.76 81.15 
8 46.94 84.95 
9 52.07 89.31 
10 51.97 91.47 
11 55.87 93.89 
12 60.76 95.17 
TABLE II. Increase of the degradation rate (%) of active ingredient (diazepam and 
alprazolam) in Bensedin® and Ksalol® by passing through the DBD reactor 
Number of passes Active ingredient Diazepam in Bensedin® Alprazolam in Ksalol® 
0 0 0 
1 2.59 1.92 
2 4.62 3.45 
3 7.44 4.90 
4 8.35 5.65 
5 9.01 6.24 
6 10.69 7.34 
7 11.76 7.68 
8 12.91 9.84 
9 14.28 10.34 
10 14.63 9.91 
11 15.41 11.17 
12 32.23 11.83 
DBD reactor we used 24,25 can produce oxidative species such as ozone, the 
ultraviolet (UV) radiation, free electrons, short-lived radicals and ions26,27. The 
trend of decrease in diazepam and alprazolam concentration, in our experiment, 
may be explained by the fact that the fall of concentration decreases the 
possibility of the effective collision of the test substance molecules with the 
oxidizing agent. On the other hand, each subsequent pass of solution through the 
DBD reactor increases the amount of degradation products, which may also 
further react with the oxidizing agent, additionally diminishing the possibility of 
the effective collision of the test substance molecules with the oxidizing agent. 
(CC) 2017 SCS. All rights reserved.
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What is evident in alprazolam is a far higher rate of degradation, achieved 
with fewer passes through the DBD reactor. Considering that the experimental 
conditions were identical, the explanation of this phenomenon might be related to 
the alprazolam structure. It has been shown that during benzodiazepine oxidation 
a cleavage in nitrogen-carbon double bond occurs most commonly.34 Besides 
that, the alprazolam carbon C4 (Fig. 1)35 is more susceptible to oxidation than the 
diazepam carbon C3 (Fig. 1),36 and the probability of the effective collision, that 
would result in oxidation, is by far higher in alprazolam.  
 
Fig. 1. Diazepam and alprazolam structure. 
The hydrolysis of the benzodiazepines ring is the most frequently observed 
degradation routes for benzodiazepines.35 The hydrolysis of diazepam in both 
acidic and basic media was observed, and it may occur in two ways. However, 
either of these ways results in the same end products of hydrolysis.34  
In the case of alprazolam, the hydrolysis, even under several different con-
ditions, was not a major degradation source.35 The aromatic diazo ring of alpra-
zolam probably protects it from hydrolysis, ensuring its better stability in both 
acidic and alkaline environment.34 
Some authors describe the degradation of this kind of compounds using a 
photodegradation method, such as UV irradiation,34 light-stress exposure testing 
with a medium-pressure metal halide lamp and mirrors35 or photolysis under con-
ditions simulating the natural sunlight.36 This kind of degradation could produce 
some oxidative species.37 
It is shown in the Table II that the rate of diazepam and alprazolam degrad-
ation in Bensedin® and Ksalol® finished products was not identical when com-
pared to the degradation of the APIs themselves. With the same number of 
passes, a lower percentage of the API degradation in the finished product was 
observed, which may be ascribed to the oxidation agent being spent on the exci-
pients contained in the finished products. The oxidative species produced during 
(CC) 2017 SCS. All rights reserved.
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the DBD reactor operation are extremely reactive, nonselective, producing an 
almost instantaneous reaction. The results presented in the Table II show an 
abrupt rise in the rate of diazepam degradation in Bensedin® at one point, indi-
cating that the oxidation of excipients already occurred, after which the consider-
able degradation of diazepam began. 
This phenomenon was also described in some other papers. After phenol was 
treated by DBD reactor, the lower removal from samples prepared with Danube 
river water could be explained by the protective effect of fulvic and humic acids 
which also reacted with ozone. It could be concluded that ozone reacted with 
different organic components present in the water.24,25 
Liu et al. reported removal of carbamazepine in an aqueous solution using ex 
situ and in situ discharge DBD reactors.18 The ozone concentration was fixed at 
the same value of 40 mg L–1 for the two systems. The absorbance decrease, 
measured on UV detector, shows that the degradation of carbamazepine in ex situ 
discharge was rapid (decrease of absorbance for about 80 %) according to the 
degradation in the in situ discharge, where degradation was very slow (decrease 
of absorbance for about 40 %).18 
Magureanu et al. investigated the decomposition of pentoxifylline in aque-
ous solution, using a dielectric barrier discharge (DBD), where oxygen was intro-
duced through a separate entrance in the upper lid of the reactor.19 After plasma 
treatment (for concentration of 50 mg L–1) about 90 % removal of pentoxifylline 
was achieved.19 
After ozonization in DBD reactor, the percentage of removed phenol, 2-
chlorophenol, 4-chlorophenol and 2,4-dichlorophenol, 2,6-dichlorophenol from 
bidistilled water was between 84.9 and 99.9 %.25,26 
While working with diazepam and alprazolam samples, used in our experi-
ment, an increase of the solution pH value was observed after the sample passing 
through the DBD reactor. Such observations were contrary to the previous obser-
vations on this reactor, when the pH of distilled water decreased as well, which 
might be explained by the cleavage of water molecules, i.e., by the participation 
of hydroxyl groups in the ozone generation.24 In the case of diazepam and alpra-
zolam, it might be assumed that during the molecule disintegration, a protonation 
of certain negatively charged atoms, produced by bonds cleavage, occurs along 
with OH ions formation. That was the reason for performing the experiment with 
the pH adjustment to the initial value (3.00) after each pass through the DBD 
reactor and the testing of the solution pH influence on the rate of degradation. 
The initial pH value of the solution was 3.00. After each pass a 100 mL 
aliquot of solution was withdrawn, while the remaining solution was acidified to 
pH 3.00. The pH was measured after each pass through the DBD reactor and 
was, with minor fluctuations, approximately about 4.5 of pH units. Diazepam and 
alprazolam samples were passed through the DBD reactor for 7 times. 
(CC) 2017 SCS. All rights reserved.
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Table III shows the rate of diazepam degradation depending on the number 
of passes through the DBD reactor and pH adjustment between the passes. 
TABLE III. Increase of the degradation rate (%) of diazepam and alprazolam (with corrected 
pH) by passing through the DBD reactor 
Number of passes Active ingredient Diazepam Alprazolam 
0 0 0 
1 12.28 15.04 
2 23.09 25.11 
3 31.24 42.62 
4 37.87 49.45 
5 42.67 54.07 
6 49.73 63.36 
7 53.15 74.91 
The results which are presented in the tables Tables I and III show that the 
acidification of a solution, after each pass, has no important impact on the rates 
of diazepam and alprazolam degradation. 
CONCLUSIONS 
The rate of diazepam and alprazolam degradation, depending on the number 
of passes through the DBD reactor, was tested, as well as the influence of 
excipients contained in Bensedin® and Ksalol® finished products, on the rate of 
degradation. Based on the results obtained, it may be concluded that DBD for 
AOP has been proved as a highly effective method for the removal of tested APIs 
from the water, since high degradation rate was obtained for the otherwise poorly 
degradable compounds (diazepam: 61 %, alprazolam: 95 %). 
This method has not been proved effective enough in the degradation of 
finished products, containing the above mentioned active substances, due to a 
great consumption of oxidative species (e.g., ozone) on degradation of the excipi-
ents contained in the finished products. A large amount of energy was spent on 
these readily biodegradable compounds, which reduced the cost-effectiveness of 
this procedure. 
It has been demonstrated that the pH adjustment, between the passes of dia-
zepam and alprazolam sample through the DBD reactor, has no important inf-
luence on the rate of degradation process. 
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И З В О Д  
ДЕГРАДАЦИЈА БЕНЗОДИАЗЕПИНА У РЕАКТОРУ СА ДИЕЛЕКТРИЧНИМ 
БАРИЈЕРНИМ ПРАЖЊЕЊЕМ КРОЗ ТАНКИ ВОДЕНИ ФИЛМ 
ВЕСНА М. РАДУЛОВИЋ1, ГОРАН М. РОГЛИЋ2 и ДРАГАН Д. МАНОЈЛОВИЋ2 
1Галеника a.д. Београд, Батајнички друм б.б. 11080 Београд и 2Хемијски факултет, Универзитет у 
Београду, Студентски трг 12-16, 11000 Београд 
Класичне методе пречишћавања отпадних вода често нису погодне за третирање 
фармацеутског отпада. Досадашња истраживања су показала да употреба унапређених 
оксидационих поступака (AOP) може довести до ефикасније деградације различитих 
билошки активних једињења, која представљају активне фармацеутске супстанце при-
мењиваних лекова. Циљ овог рада је примена плазма технологије за деградацију две 
активне фармацеутске супстанце (диазепам и алпразолам) и готових производа (Ben-
sedin® and Ksalol®) у реактору са диелектричним баријерним пражњењем (DBD), као 
унапређеног оксидационог процеса (AOP). Испитиван је степен деградације ових фар-
мацеутика, у зависности од броја пролаза кроз реактор. Овај метод деградације се 
показао ефикасним: за диазепам 61 %, а за алпразолам 95 %. Испитиван је и утицај pH 
подешавања између пролаза APIs кроз DBD реактор. Степен деградације API и готових 
производа праћен је HPLC техником помоћу фотодиодног детектора. Концентрација 
раствореног озона одређена је јодометријским поступком. 
(Примљено 18. јануара, ревидирано 22. априла, прихваћено 25. априла 2017) 
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